Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains.
Open accessAbstract
The stability and structure of human apolipoprotein (apo) E3 in aqueous solution were investigated by guanidine HCl denaturation and limited proteolysis. The guanidine HCl denaturation curve, as monitored by circular dichroism spectroscopy, was biphasic; the two transition midpoints occurred at 0.7 and 2.5 M guanidine HCl, indicating that there are stable intermediate structures in the unfolding of apoE. Limited proteolysis of apoE with five enzymes demonstrated two proteolytically resistant regions, an amino-terminal domain (residues 20-165) and a carboxyl-terminal domain (residues 225-299). The region between them was highly susceptible to proteolytic cleavage. Because of their similarity to the proteolytically resistant regions, the amino-terminal (residues 1-191) and carboxyl-terminal (residues 216-299) thrombolytic fragments of apoE were used as models for the two domains. Guanidine HCl denaturation of the carboxyl- and amino-terminal fragments gave transition midpoints of 0.7 and 2.4 M guanidine HCl, respectively. The results establish that the two domains identified by limited proteolysis correspond to the two domains detected by protein denaturation experiments. Therefore, the thrombolytic fragments are useful models for the two domains. The free energies of denaturation calculated from the denaturation curves of intact apoE or the model domains were approximately 4 and 8-12 kcal/mol for the carboxyl- and amino-terminal domains, respectively. The value for the carboxy…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The second unfolding transition of apoE3 variant corresponds to the unfolding of the N-terminal domain where the K146E mutation is located.
“of the second unfolding transition of apoE3 variant (Table 3) that corresponds to the unfolding of the N-terminal domain where the K146E mutation is located [13], [44], [65].”
From Biophysical Analysis of Apolipoprotein E3 Variants Linked with Development of Type III Hyperlipoproteinemia (2011) · cites this paper as [13]
Lipid-free apoE is folded into two seemingly independent structural domains that can be separated after digestion with thrombin, generating an N-terminal, 22-kDa fragment (residues 1-191) and a C-terminal, 10-kDa fragment (residues 216-299).
“Lipid-free apoE is folded into two seemingly independent structural domains that can be separated after digestion with thrombin, generating an N-terminal, 22-kDa fragment (residues 1-191) and a C-terminal, 10-kDa fragment (residues 216 -299) (21,22).”
From Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4 (2014) · cites this paper as [21]
The amino- and carboxyl-terminal structural domains of apoE appear to be independently folded.
“Even though the amino- and carboxyl-terminal structural domains of apoE appear to be independently folded (12, 29), evidence suggests that the carboxyl-terminal domain can modulate the receptor binding function of the amino-terminal domain (25).”
From Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121–127 (1989) · cites this paper as [12]
Residues 121-127 in apoE3 constitute nearly two full turns of a predicted α-helix.
“Residues 121– 127 in apoE3 constitute nearly two full turns of a predicted α-helix (12).”
From Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121–127 (1989) · cites this paper as [12]
ApoE contains N-terminal and C-terminal domains that unfold independently.
“ApoE contains N-terminal and C-terminal domains that unfold independently ( 42,43 ).”
From Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4 (2011) · cites this paper as [42]
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 42 · Cited by 293
- Authors
- Wetterau, J. R., Aggerbeck, L. P., Rall, S. C., & Weisgraber, K. H.
- Affiliations
- University of California, San Francisco (US)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1988-05
- Volume
- 263
- Issue
- 13
- Pages
- 6240-6248
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1529259401
- Cited by
- 293
- References
- 42
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 5 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 11 · 2018: 6 · 2017: 5 · 2016: 5 · 2015: 4 · 2014: 8 · 2013: 9 · 2012: 7
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL 18577-11)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Keywords
- apolipoprotein E3, protein structure, structural domains, guanidine hydrochloride denaturation, limited proteolysis, N-terminal domain, C-terminal domain, hinge region, protein stability, apolipoproteins
- MeSH terms
- Algorithms, Apolipoproteins E, Circular Dichroism, Electrophoresis, Polyacrylamide Gel, Guanidines, Humans, Hydrolysis, Protein Conformation, Protein Denaturation, Solutions, Time Factors, Guanidine, Apolipoprotein E3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review